Background Psoriatic arthritis (PsA) is a multifaceted condition with a broad spectrum of
manifestations and a range of associated comorbidities. A notable segment of patients with …

Psoriatic arthritis (PsA) is a chronic inflammatory disease primarily affecting peripheral and
axial joints, with the possible presence of extra-articular manifestations (EAMs), such as …

Abstract Objective: Update the French Society for Rheumatology (SFR) recommendations
on the everyday management of patients with spondyloarthritis, including psoriatic arthritis …

Introduction The EULAR group recently published the definition of difficult-to-treat (D2T)
patients for rheumatoid arthritis. However, a similar definition is lacking for patients with …

Introduction Sleep disturbances, fatigue, and anxiety/depression in psoriatic arthritis (PsA)
may be influenced by skin and musculoskeletal manifestations. All of these in turn affect the …

Background Scanty data on the immunogenicity of the BNT162b2 vaccine in patients with
psoriatic arthritis (PsA) on Tumor Necrosis Factor inhibitors (TNFi) have been published …

Ultrasound-guided synovial tissue biopsy (USSB) may allow personalizing the treatment for
patients with inflammatory arthritis. To this end, the quantification of tissue inflammation in …

The main symptom in patients with axial spondyloarthritis (axSpA) is inflammatory back pain,
caused principally by inflammation of the sacroiliac joints and the spine. However, not all …

Objectives We aimed to evaluate the (a) potential predictors of first biological disease-
modifying anti-rheumatic drug (bDMARD) failure and (b) factors associated with failure of …

Psoriasis is a chronic inflammatory cutaneous condition characterized by several
comorbidities, including musculoskeletal disorders. While the association with psoriatic …